1530
H. B. Borate et al. / Tetrahedron Letters 54 (2013) 1528–1530
2. Borate, H. B.; Kudale, A. S.; Agalave, S. G. Org. Prep. Proced. Int. 2012, 44, 467–
Ar
H
O
O
CN
CN
+
+
Acid or base
Acid or base
521.
R
Ar
H
3. (a) Chamorro, G.; Garduño, L.; Sánchez, A.; Labarrios, F.; Salazar, M.; Martínez,
E.; Diaz, F.; Tamariz, J. Drug Dev. Res. 1998, 43, 105–108; (b) Labarrios, F.;
Garduño, L.; Vidal, M. D. R.; Garcia, R.; Salazar, M.; Martínez, E.; Diaz, F.;
Chamorro, G.; Tamariz, J. J. Pharm. Pharmacol. 1999, 51, 1–7; (c) Popławski, J.;
Łozowicka, B.; Dubis, A. T.; Lachowska, B.; Witkowski, S.; Siluk, D.; Petrusewicz,
J.; Kaliszan, R.; Cybulski, J.; Strzałkowska, M.; Chilmonczyk, Z. J. Med. Chem.
2000, 43, 3671–3676; (d) Magdziarz, T.; Łozowicka, B.; Gieleciak, R.; Ba˛k, A.;
Polan´ ski, J.; Chilmonczyk, Z. Bioorg. Med. Chem. 2006, 14, 1630–1643.
4. (a) Tuntiwachwuttikul, P.; Pancharoen, O.; Jaipetch, T.; Reutrakul, V.
Phytochemistry 1981, 20, 1164–1165; (b) Mangold, B. L. K.; Hanna, P. E. J.
Med. Chem. 1982, 25, 630–638.
NC
R
CN
Ar
H
H
Base
+
NC
CN
NC
CN
CN
CN
H
I
II
R
H
NC
CN
Ar
R
Ar
R
NC
NC
Ar
NC
CN
R
CN
NC
3
CN
CN
5. (a) Sharma, A.; Joshi, B. P.; Sinha, A. K. Bull. Chem. Soc. Jpn. 2004, 77, 2231–2235;
(b) Kumar, R.; Sharma, A.; Sharma, N.; Kumar, V.; Sinha, A. K. Eur. J. Org. Chem.
2008, 5577–5582.
III
IV
6. Peyroux, E.; Berthiol, F.; Doucet, H.; Santelli, M. Eur. J. Org. Chem. 2004, 1075–
1082.
Scheme 3. The proposed mechanism for formation of olefin 3.
7. (a) Shulgin, A. T. Can. J. Chem. 1965, 43, 3437–3440; (b) Mayer, M.; Welther, A.;
von Wangelin, A. J. ChemCatChem 2011, 3, 1567–1571.
8. Mirk, D.; Grassot, J.-M.; Zhu, J. Synlett 2006, 1255–1259.
9. Zhang, H.-P.; Dai, Y.-Z.; Zhou, X.; Yu, H. Synlett 2012, 1221–1224.
10. Xie, L.-G.; Wang, Z.-X. Chem. Eur. J. 2011, 17, 4972–4975.
11. (a) Green, B.; Khaidem, I. S.; Crane, R. I.; Newaz, S. S. Tetrahedron 1976, 32,
2997–3001; (b) Khaidem, I. S.; Singh, S. L.; Singh, L. R.; Khan, M. Z. R. Indian J.
Chem. 1996, 35B, 911–914; (c) Helmy, N. M.; El-Baih, F. E. M.; Al-Alshaikh, M.
A.; Moustafa, M. S. Molecules 2011, 16, 298–306.
Knoevenagel product is formed and the olefinic product is not ob-
tained. Ammonium acetate can be replaced with ammonium
formate while acetic acid can be replaced with proline or alanine
affording similar yields. Although the exact mechanism has not
been ascertained, the proposed plausible mechanism for the pres-
ent reaction is depicted in Scheme 3.
In conclusion, the present manuscript reports preliminary
results19 about a conceptually new method for the synthesis of
various aryl olefins using easily available starting materials. The
products obtained can be studied for various biological activities
as aryl olefins are known to exhibit hypolipidemic activity3 and
antiplatelet activity3c or they can be used as intermediates for
the synthesis of new molecules taking advantage of various func-
tional groups as depicted in Table 1. Due to the easy availability
of starting materials and potential to prepare aryl olefins with a
variety of substituents, this method would be useful in organic
synthesis as well as medicinal chemistry.
12. Lawrence, N. J.; Beynek, H. Synlett 1998, 497–498.
13. Spectral data for all olefins prepared by this method are given in the
Supplementary data.
Preparation of (E)-5-(hex-1-en-1-yl)-1,2,3-trimethoxybenzene: To a mixture of
3,4,5-trimethoxybenzaldehyde (0.784 g, 0.004 mol), hexanal (0.5 g, 0.005 mol)
and malononitrile (0.66 g, 0.01 mol), was added 30 ml of acetonitrile followed
by the addition of glacial acetic acid (0.42 ml 0.0075 mol). The reaction mixture
was stirred for 10 min and then ammonium acetate (0.385 g, 0.005 mol) was
added. The reaction was stirred at 80 °C for 8 h. The mixture was then allowed
to come to room temperature, filtered through Whatmann filter paper and the
filtrate was concentrated on rotavapor. The residual oil was then partitioned
between water and ethyl acetate and the organic extract was dried over
sodium sulfate, concentrated and purified over silica gel using ethyl acetate-
pet ether (3% ethyl acetate in pet ether) as an eluent to give (E)-5-(hex-1-en-1-
yl)-1,2,3-trimethoxybenzene as
a
colourless liquid (0.6 g, 60%); IR
(chloroform): 810, 925, 1377, 1506, 1582, 1651, 2929, 2989 cmÀ1
.
1H NMR
Acknowledgment
(200 MHz, CDCl3): d 0.93 (t, J = 7 Hz, 3H), 1.30–1.56 (m, 4H), 2.27 (q, J = 7 Hz,
2H), 3.84 (s, 3H), 3.88 (s, 6H), 6.14 (dt, J = 16, 7 Hz, 1H), 6.32 (d, J = 16 Hz, 1H),
6.58 (s, 2H); 13C NMR (50 MHz, CDCl3): d 13.7, 22.0, 31.3, 32.4, 55.7 (2C), 60.6,
102.6 (2C), 129.4, 130.5, 133.5, 136.9, 153.0 (2C); HRMS (ESI) m/z calcd for
[C15H22O3 + Na]+: 273.1461, found 273.1462; [C15H22O3 + H]+: 251.1642, found
251.1642.
We thank DST, New Delhi and FDC Ltd, Mumbai for partial
financial support.
14. Han, L.-B.; Kambe, N.; Ogawa, A.; Ryu, I.; Sonoda, N. Organometallics 1993, 12,
473–477.
Supplementary data
15. Hodgson, D. M.; Fleming, M. J.; Stanway, S. J. J. Org. Chem. 2007, 72, 4763–4773.
16. Hadebe, S. W.; Sithebe, S.; Robinson, R. S. Tetrahedron 2011, 67, 4277–4282.
17. Negishi, E.; Takahashi, T.; Baba, S.; Van Horn, D. E.; Okukado, N. J. Am. Chem.
Soc. 1987, 109, 2393–2401.
18. Bauld, N. L.; Yang, J. J. Phys. Org. Chem. 2000, 13, 518–522.
19. Provisional Indian patent filed; Provisional Filing Number: 3486/DEL/2012 dt
Nov 9, 2012.
Supplementary data (experimental procedures and spectral
data) associated with this article can be found, in the online ver-
References and notes
1. Sawargave, S. P.; Kudale, A. S.; Deore, J. V.; Bhosale, D. S.; Divse, J. M.; Chavan, S.
P.; Borate, H. B. Tetrahedron Lett. 2011, 52, 5491–5493.